Parcion Private Wealth LLC acquired a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,352,904 shares of the company's stock, valued at approximately $15,670,000. LifeStance Health Group makes up approximately 1.3% of Parcion Private Wealth LLC's portfolio, making the stock its 20th largest position. Parcion Private Wealth LLC owned approximately 0.61% of LifeStance Health Group as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. LPL Financial LLC increased its position in LifeStance Health Group by 6.0% in the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company's stock valued at $277,000 after buying an additional 2,127 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in LifeStance Health Group by 2.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock valued at $1,023,000 after purchasing an additional 3,305 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new position in LifeStance Health Group during the 1st quarter valued at about $31,000. MetLife Investment Management LLC boosted its stake in LifeStance Health Group by 6.8% during the 4th quarter. MetLife Investment Management LLC now owns 85,914 shares of the company's stock valued at $633,000 after purchasing an additional 5,492 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in shares of LifeStance Health Group by 4.6% in the 4th quarter. Legal & General Group Plc now owns 134,557 shares of the company's stock worth $992,000 after buying an additional 5,917 shares during the last quarter. 85.50% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on the company. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp initiated coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price on the stock. Finally, UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target on the stock in a report on Tuesday, May 27th. One equities research analyst has rated the stock with a sell rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $8.50.
View Our Latest Research Report on LifeStance Health Group
Insider Buying and Selling at LifeStance Health Group
In other news, insider Ujjwal Ramtekkar sold 16,000 shares of the company's stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total value of $95,040.00. Following the transaction, the insider owned 113,435 shares of the company's stock, valued at approximately $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 3.20% of the company's stock.
LifeStance Health Group Stock Performance
LFST stock traded down $0.20 during midday trading on Friday, reaching $4.22. 2,154,414 shares of the company's stock traded hands, compared to its average volume of 1,677,748. The company has a 50-day moving average price of $5.29 and a two-hundred day moving average price of $6.58. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.47 and a current ratio of 1.47. LifeStance Health Group, Inc. has a 52 week low of $4.22 and a 52 week high of $8.61. The firm has a market capitalization of $1.64 billion, a PE ratio of -42.20 and a beta of 1.16.
About LifeStance Health Group
(
Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Recommended Stories
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
